Frontlight ResearchEarly access
Mesothelioma trials in Puerto Rico
1 of 1 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Where
- San Juan
- Age
- 18 years to 80 years
- People
- 242 worldwide
- Run by
- VM Oncology, LLC
See details and how to joinNCT03556228